Jacobs Bruce N. sold KYMR
September 17, 2025 · Form 4 insider transaction
Jacobs Bruce N. sold 36,974 shares of Kymera Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
36,974
Price
$0.00
Total value
N/A
InsiderJacobs Bruce N.
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeM: Option exercise
Transaction dateSeptember 17, 2025
Filing dateSeptember 17, 2025
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person.; The shares underlying this stock option are fully vested and exercisable.